Clinical Trial Update: TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update for TD-1792 in Gram-positive skin infections has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-positive Skin and Skin Structure Infection
• Staphylococcal Skin Infection

Drugs mentioned

• TD-1792

Snippet

Sponsor: Theravance Biopharma | Conditions: Staphylococcal Skin Infection | Phase 2 | Status: COMPLETED